Walajtys-Rhode E, Zapatero J, Moehren G, Hoek J B
Department of Pathology and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
J Biol Chem. 1992 Jan 5;267(1):370-9.
The effect of Ca2+ on the rate of pyruvate carboxylation was studied in liver mitochondria from control and glucagon-treated rats, prepared under conditions that maintain low Ca2+ levels (1-3 nmol/mg of protein). When the matrix-free [Ca2+] was low (less than 100 nM), the rate of pyruvate carboxylation was not significantly different in mitochondria from control and glucagon-treated rats. Accumulation of 5-8 nmol of Ca2+/mg, which increased the matrix [Ca2+] to 2-5 microM in both preparations, significantly enhanced pyruvate carboxylase flux by 20-30% in the mitochondria from glucagon-treated rats, but had little effect in control preparations. Higher levels of Ca2+ (up to 75 nmol/mg) inhibited pyruvate carboxylation in both preparations, but the difference between the mitochondria from control and glucagon-treated animals was maintained. The enhancement of pyruvate dehydrogenase flux by mitochondrial Ca2+ uptake was also significantly greater in mitochondria from glucagon-treated rats. These differential effects of Ca2+ uptake on enzyme fluxes did not correlate with changes in the mitochondrial ATP/ADP ratio, the pyrophosphate level, or the matrix volume. Arsenite completely prevented 14CO2 incorporation when pyruvate was the only substrate, but caused only partial inhibition when succinate and acetyl carnitine were present as alternative sources of energy and acetyl-CoA. Under these conditions, mitochondria from glucagon-treated rats were less sensitive to arsenite than the control preparations, even at low Ca2+ levels. We conclude that the Ca(2+)-dependent enhancement of pyruvate carboxylation in mitochondria from glucagon-treated rats is a secondary consequence of pyruvate dehydrogenase activation; glucagon treatment is suggested to affect the conditions in the mitochondria that change the sensitivity of the pyruvate dehydrogenase complex to dephosphorylation by the Ca(2+)-sensitive pyruvate dehydrogenase phosphatase.
在低钙水平(1 - 3纳摩尔/毫克蛋白质)条件下制备的对照大鼠和胰高血糖素处理大鼠的肝脏线粒体中,研究了Ca2+对丙酮酸羧化速率的影响。当无基质[Ca2+]较低(低于100纳摩尔/升)时,对照大鼠和胰高血糖素处理大鼠的线粒体中丙酮酸羧化速率无显著差异。积累5 - 8纳摩尔Ca2+/毫克,使两种制剂中的基质[Ca2+]增加到2 - 5微摩尔,显著增强了胰高血糖素处理大鼠线粒体中丙酮酸羧化酶通量20 - 30%,但对对照制剂影响不大。更高水平的Ca2+(高达75纳摩尔/毫克)抑制了两种制剂中的丙酮酸羧化,但对照动物和胰高血糖素处理动物的线粒体之间的差异仍然存在。胰高血糖素处理大鼠的线粒体中,线粒体Ca2+摄取对丙酮酸脱氢酶通量的增强作用也明显更大。Ca2+摄取对酶通量的这些差异效应与线粒体ATP/ADP比值、焦磷酸水平或基质体积的变化无关。当丙酮酸是唯一底物时,亚砷酸盐完全阻止了14CO2掺入,但当琥珀酸和乙酰肉碱作为能量和乙酰辅酶A的替代来源存在时,仅引起部分抑制。在这些条件下,即使在低Ca2+水平下,胰高血糖素处理大鼠的线粒体比亚砷酸盐对照制剂更不敏感。我们得出结论,胰高血糖素处理大鼠线粒体中Ca(2+)依赖性丙酮酸羧化增强是丙酮酸脱氢酶激活的次要结果;提示胰高血糖素处理影响线粒体中的条件,从而改变丙酮酸脱氢酶复合物对Ca(2+)敏感的丙酮酸脱氢酶磷酸酶去磷酸化的敏感性。